United States

The US FDA has approved Israeli firm Teva Pharmaceutical Industries's generic version of US company Merck & Co's Proscar (finasteride) for the treatment of benign prostatic hyperlasia.... 2006-06-20

The American Medical Association is petitioning for a temporary bans on direct-to-consumer (DTC) advertising for newly approved prescription pharmaceuticals, with the length of embargo... 2006-06-19

The introduction of radio frequency identification (RFID) to pharmaceutical packages in the US will not occur by 2007 as previously hoped.

The US FDA has approved Swiss firm Sandoz' Omnitrope (somatropin) for the treatment of growth hormone deficiency, marking the first time the agency has registered a generic version... 2006-06-05

US drug major Schering-Plough is to close its manufacturing facility in Manati, Puerto Rico by the end of this year, according to international reports. Job losses are expected to... 2006-06-05

US drugmaker Pfizer is talking up it best-selling medicine - the blockbuster cholesterol-lowering Lipitor (atorvastatin) - as it begins to face competition from cheaper generic versions... 2006-05-22

Wyeth is to join the list of likely bidders for the over-the-counter medicines portfolio of fellow US pharmaceuticals giant Pfizer. The offer echoes a bid made by Wyeth's predecessor... 2006-05-19

In addition to legal disputes, there are also practical reasons that can lead to delays in the approval of generic products in the US - in particular the fact that the FDA's Office... 2006-05-09

Swiss firm Novartis has become a full-spectrum pharmaceutical company through its acquisition of the 56% stake in US-based Chiron that it did not already

Israel's Teva Pharmaceutical Industries is to receive 180-day US marketing exclusivity on its generic formulation of pravastatin sodium, better known as Bristol-Myers Squibb's blockbuster... 2006-04-21